Erratum: Equivalence of glatiramer acetate generics with branded glatiramer acetate in efficacy and cost for the treatment of multiple sclerosis (JAMA Neurol. (2015) 1-3 10.1001/jamaneurol.2015.2605)

D. Bourdette, D. Hartung

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: Equivalence of glatiramer acetate generics with branded glatiramer acetate in efficacy and cost for the treatment of multiple sclerosis (JAMA Neurol. (2015) 1-3 10.1001/jamaneurol.2015.2605)'. Together they form a unique fingerprint.